Related Experiment Video
Updated: Aug 30, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Neuroprotective effects of early antiretrovirals in vertical HIV infection
Silvia Sánchez-Ramón1, Salvador Resino, José M Bellón Cano
1Unit of Neuroimmunology, Laboratory of Immuno-Molecular Biology, Madrid, Spain
Abstract:
We performed a retrospective study of a series of 58 of 189 vertically HIV-1 infected children who went on to develop progressive HIV-1-associated encephalopathy to assess real-life effects of early antiretroviral therapy on neurologic outcome. Our findings clearly indicate that antiretroviral therapy before the onset of neurologic symptoms delayed presentation of progressive HIV-1-associated encephalopathy, with an additional beneficial effect on survival.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Cryptococcal Meningitis
Respiratory Syncytial Virus Disease
